|
S(R)]-N-[(S)-[1,1':3',1''-terphenyl]-5'-yl(2-(diphenylphosphanyl) phenyl)methyl]-N,2-dimethyl-2-propanesulfinamide
|
|
|
|
(R,E)-N-(2-(diphenylphosphanyl)benzylidene)-2-methylpropane-2-sulfinamide
|
|
2413724-67-9
|
|
S(R)]-N-[(S)-(2-(1-tert-Butylmethyl)][5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]methyl]-N,2-dimethyl-2-propanesulfinamide
|
|
|
|
S(R)]-N-[(R)-[2-(Diadamantanphosphino)phenyl]phenylmethyl]-2-methyl-2-propanesulfinamide
|
|
|
|
S(R)]-N-[(S)-[(3-(Benzyloxy)-2-(dicyclohexylphosphino)phenyl]-(1,1'-biphenyl)methyl]-N,2-dimethyl-2-propanesulfinamide
|
|
|
|
S(R)]-N-[(S)-[5-(Diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]phenylmethyl]-N,2-dimethyl-2-propanesulfinamide
|
|
|
|
[S(R)]-N-[(R)-(5-trifluoromethyl)(2-(diphenylphosphanyl) phenyl)methyl]-N,2-methyl-2-propanesulfinamide
|
|
|
|
VX-984(M9831)
|
|
1801756-06-8
|
|
EVT801
|
|
2750709-91-0
|
|
Tunlametinib（HL-085）
|
|
1412453-70-3
|
|
[S(R)]-N-[(S)-[2-(Dicyclohexylphosphino)-4,5-dimethoxyphenyl)](4-phenyl)methyl]-N,2-methyl-2-propanesulfinamide
|
|
|
|
[S(R)]-N-[(S)-(5-trifluoromethyl)(2-(Dicyclohexylphosphino) phenyl)methyl]-2-methyl-N,2-propanesulfinamide
|
|
|
|
S(R)]-N-((1S)-1-(2-(Dicyclohexylphosphino)phenyl)ethyl)-2-methyl-2-propanesulfinamide
|
|
|
|
S(R)]-N-[(S)-[3,5-Bis(trifluoromethyl)phenyl][5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]methyl]-N,2-dimethyl-2-propanesulfinamide
|
|
|
|
S(R)]-N-[(R)-(3,5-Di-tert-butyl-4-methoxyphenyl)[2-(diphenylphosphino)-4,5-dimethoxyphenyl]-N,2-dimethyl-2-propanesulfinamide
|
|
|
|
BI-4732
|
|
2374971-81-8
|
|
CPI-1612
|
|
1637677-33-8
|
|
[S(R)]-N-[(R)-(5-trifluoromethyl)(2-(Dicyclohexylphosphino) phenyl)methyl]-2-methyl-N,2-propanesulfinamide
|
|
|
|
ME-344
|
|
2131210-15-4
|
|
Povorcitinib phosphate(INCB54707 phosphate)
|
|
1374524-68-1
|
|
S(R)]-N-[(S)-1-[2-(Dicyclohexylphosphino)phenyl]-(1,1'-biphenyl)methyl]-2-methyl-2-propanesulfinamide
|
|
|
|
S(R)]-N-[(R)-[2-(1-Adamantylmethyl)][5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]methyl]-N,2-dimethyl-2-propanesulfinamide
|
|
|
|
NT-0796
|
|
2769715-68-4
|
|
S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl]-(1,1'-biphenyl)methyl]-2-methyl-2-propanesulfinamide
|
|
|
|
N-[(S)-1-((r)-2-(anthracen-9-yl)phenyl)-2-(diphenylphosphanyl)ethyl]-3,5-bis(trifluoromethyl)benzamide
|
|
|
|
Aldosterone
|
|
1476074-39-1
|
|
OPB-171775
|
|
52-39-1
|
|
S(R)]-N-[(S)-[2-(Diadamantanphosphino)phenyl]phenylmethyl]-N,2-dimethyl-2-propanesulfinamide
|
|
|
|
S(R)]-N-[(S)-(4-(tert-Butyl)phenyl)[2-(diphenylphosphino)phenyl]methyl]-2-methyl-2-propanesulfinamide
|
|
|
|
S(R)]-N-[(S)-[1,1'-biphenyl]-4-yl(5-(diphenylphosphanyl)-9,9-dimethyl-9H-xanthen-4-yl)methyl]-2-methylpropane-2-sulfinamide
|
|
|
|
S(R)]-N-[(R)-[5-(Diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl](4-methoxyphenyl)methyl]-2-methyl-2-propanesulfinamide
|
|
2757083-09-1
|
|
SRX3177
|
|
2869954-34-5
|
|
DSP5336
|
|
2241237-51-2
|
|
D3S-001
|
|
2512197-69-0
|
|
ADT-007
|
|
2914919-85-8
|
|
(R,R)-BINAPHOS
|
|
|
|
HRO761
|
|
2272917-13-0
|
|
PROTAC BRD9 Degrader-1
|
|
1945941-09-2
|
|
Azelaprag (AMG 986)
|
|
496775-95-2
|
|
ML-099(CID-888706)
|
|
916489-36-6
|
|
Silane, ethynyltris(2-methylpropyl)-
|
|
2049980-18-7
|
|
S(R)]-N-[(1S)-1-(2',6'-Diisopropyl)-(1,1'-biphenyl)-2-yl]-2-(diphenylphosphino)ethyl]-2-methyl-2-propanesulfinamide
|
|
|